A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy

Leukemia Research

Volumn 28, Issue 6, 2004, Pages 559-565

  Giles, Francis J ^a   Rodriguez, Roberto ^b   Weisdorf, Daniel ^c   Wingard, John R ^d   Martin, Paul J ^e   Fleming, Thomas R ^f   Goldberg, Stuart L ^g   Anaissie, Elias J ^h   Bolwell, Brian J ⁱ   Chao, Nelson J ^j   Shea, Thomas C ^k   Brunvand, Mark M ^l   Vaughan, William ^m   Petersen, Finn ⁿ   Schubert, Mark ^o   Lazarus, Hillard M ^p   Maziarz, Richard T ^q   Silverman, Margarida ^r   Beveridge, Roy A ^s   Redman, Rebecca ^t   Pulliam, Janis G ^t   Devitt Risse, Patricia ^t   Fuchs, Henry J ^t   Hurd, David D ^u   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j DUKE UNIVERSITY   (United States)

^k UNIVERSITY OF NORTH CAROLINA   (United States)

^l Rocky Mt Blood Morrow Transplant P   (United States)

^m UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁿ UNIVERSITY OF UTAH HOSPITAL   (United States)

^o SEATTLE CANCER CARE ALLIANCE   (United States)

^p CASE WESTERN RESERVE UNIVERSITY   (United States)

^q OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^r UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^s INOVA FAIRFAX HOSPITAL   (United States)

^t IntraBiotics Pharmaceuticals Inc   (United States)

^u WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

more..

Author keywords

Iseganan; Oral mucositis; Stomatitis; Ulcerative

Indexed keywords

ANALGESIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; ISEGANAN; METHOTREXATE; OPIATE; PEPTIDE; PLACEBO; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANXIETY DISORDER; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; FATIGUE; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PAIN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SORE THROAT; STATISTICAL SIGNIFICANCE; STOMATITIS; SWALLOWING; VOMITING;

ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; COHORT STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; NEOPLASMS; PEPTIDES; PLACEBOS; PROTEINS; QUESTIONNAIRES; STEM CELL TRANSPLANTATION; STOMATITIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 11144357269     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.10.021     Document Type: Article

References (43)

1. Sonis S., Clark J. Prevention and management of oral mucositis induced by antineoplastic therapy. Oncology (Huntingt). 5:1991;11-18
2. Dreizen S. Stomatotoxic manifestations of cancer chemotherapy. J. Prosthet. Dent. 40:1978;650-655
3. Dreizen S., McCredie K.B., Bodey G.P., Keating M.J. Quantitative analysis of the oral complications of antileukemia chemotherapy. Oral Surg. Oral Med. Oral Pathol. 62:1986;650-653
4. Development of a staging system for chemotherapy-induced stomatitis. Western Consortium for Cancer Nursing Research. Cancer Nurs 1991;14:6-12.
5. Wilkes J.D. Prevention and treatment of oral mucositis following cancer chemotherapy. Semin. Oncol. 25:1998;538-551
6. Plevova P. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review. Oral Oncol. 35:1999;453-470
7. Plevova P. Re: mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 35:1999;225-226
8. Elting L.S., Bodey G.P., Keefe B.H. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin. Infect. Dis. 14:1992;1201-1207
9. Ruescher T.J., Sodeifi A., Scrivani S.J., Kaban L.B., Sonis S.T. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer. 82:1998;2275-2281
10. Rapoport A.P., Miller Watelet L.F., Linder T., Eberly S., Raubertas R.F., Lipp J., et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J. Clin. Oncol. 17:1999;2446-2453
11. Sonis S.T., Eilers J.P., Epstein J.B. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer. 85:1999;2103-2113
12. Sonis S.T., Oster G., Fuchs H. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J. Clin. Oncol. 19:2001;2201-2205
13. Sonis S.T. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 34:1998;39-43
14. Sonis S.T., Peterson R.L., Edwards L.J. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol. 36:2000;373-381
15. Symonds R.P., McIlroy P., Khorrami J. The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial. Br. J. Cancer. 74:1996;312-317
16. Donnelly J.P., Muus P., Horrevorts A.M. Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipients. Scand. J. Infect. Dis. 25:1993;43-50
17. Epstein J.B., Vickars L., Spinelli J. Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation. Oral Surg. Oral Med. Oral Pathol. 73:1992;682-689
18. Rutkauskas J.S., Davis J.W. Effects of chlorhexidine during immunosuppressive chemotherapy. A preliminary report. Oral Surg. Oral Med. Oral Pathol. 76:1993;441-448
19. Aumelas A., Mangoni M., Roumestand C. Synthesis and solution structure of the antimicrobial peptide protegrin-1. Eur. J. Biochem. 237:1996;575-583
20. Fahrner R.L., Dieckmann T., Harwig S.S. Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem. Biol. 3:1996;543-550
21. Chen J., Falla T.J., Liu H. Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. Biopolymers. 55:2000;88-98
22. Giles F.J., Redman R., Yazji S. Iseganan HCl: a novel antimicrobial agent. Expert Opin. Invest. Drugs. 11:2002;1161-1170
23. Mosca D.A., Hurst M.A., So W. IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis. Antimicrob. Agents Chemother. 44:2000;1803-1808
24. Bellm L., Lehrer R.I., Ganz T. Protegrins: new antibiotics of mammalian origin. Expert Opin. Invest. Drugs. 9:2000;1731-1742
25. Vesole D., Fuchs H.J. IB-367 reduces the number of days of severe oral mucositis complicating myeloablative chemotherapy. Blood. 94:1999;154a
26. Giles F.J., Miller C.B., Hurd D.D. A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT TRIAL). Leukemia Lymphoma. 44:2003;1165-1172
27. Woo S.B., Sonis S.T., Monopoli M.M. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer. 72:1993;1612-1617
28. Foote R.L., Loprinzi C.L., Frank A.R. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J. Clin. Oncol. 12:1994;2630-2633
29. Ferretti G.A., Ash R.C., Brown A.T. Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine digluconate oral rinse. Bone Marrow Transplant. 3:1988;483-493
30. Ferretti G.A., Raybould T.P., Brown A.T. Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial. Oral Surg. Oral Med. Oral Pathol. 69:1990;331-338
31. Spijkervet F.K., van Saene J.J., van Saene H.K. Chlorhexidine inactivation by saliva. Oral Surg. Oral Med. Oral Pathol. 69:1990;444-449
32. Spijkervet F.K., van Saene H.K., van Saene J.J. Mucositis prevention by selective elimination of oral flora in irradiated head and neck cancer patients. J. Oral Pathol. Med. 19:1990;486-489
33. Spijkervet F.K., Van Saene H.K., Van Saene J.J. Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients. J. Surg. Oncol. 46:1991;167-173
34. Okuno S.H., Foote R.L., Loprinzi C.L. A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer. 79:1997;2193-2199
35. Loury D., Embree J.R., Steinberg D.A. Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 87:1999;544-551
36. Peterson D.E. Pretreatment strategies for infection prevention in chemotherapy patients. NCI Monogr. 9:1990;61-71
37. Peterson D.E., Minah G.E., Reynolds M.A. Effect of granulocytopenia on oral microbial relationships in patients with acute leukemia. Oral Surg. Oral Med. Oral Pathol. 70:1990;720-723
38. Ferrara J.L. Cytokines other than growth factors in bone marrow transplantation. Curr. Opin. Oncol. 6:1994;127-134
39. Bianco J.A., Appelbaum F.R., Nemunaitis J. Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood. 78:1991;1205-1211
40. Stiff P. Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant. 27(Suppl. 2):2001;S3-S11
41. Alvarado Y., Bellm L.A., Giles F.J. Oral mucositis: time for more studies. Hematology. 7:2002;281-289
42. Meropol N.J., Somer R.A., Gutheil J. Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant. J. Clin. Oncol. 21:2003;1452-1458
43. Loprinzi C.L., Martenson J.A. Keratinocyte growth factor: not yet ready for prime time. J. Clin. Oncol. 21:2003;1429-1430